Evidence map›Paper›PMID 25307159›Full record

ArticleJournal of breath research2014

Identifying methicillin-resistant Staphylococcus aureus (MRSA) lung infections in mice via breath analysis using secondary electrospray ionization-mass spectrometry (SESI-MS).

Heather D Bean, Jiangjiang Zhu, Jackson C Sengle, Jane E Hill

Open access · hybridAbstract read
In one paragraph

Article in Journal of breath research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Treatment of MRSA Infection: Where are We?Current medicinal chemistry · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Rapid detection ofiScience · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Heather D Bean *Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755, USA.
Jiangjiang Zhu *Northwest Metabolomics Research Center, University of Washington School of Medicine, 850 Republican Street, Room S140, Seattle, WA 98109, USA.
Jackson C SengleThayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755, USA.
Jane E HillThayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755, USA.
Dartmouth College · USUniversity of Washington · US

Funding

VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MATRAJT, MARIANA L · 2006 to 2011
$14.5M
Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
NCRR NIH HHS 5P20RR021905-07NCRR NIH HHS P20 RR021905NIGMS NIH HHS 8 P20 GM103496-07NIGMS NIH HHS P20 GM103496
6 · The paper itself

Abstract

Invasive methicillin-resistant Staphylococcus aureus (MRSA) infections are a serious health threat, causing an estimated 11,000 deaths per year in the United States. MRSA pneumonias account for 16% of invasive infections, and can be difficult to detect as the current state-of-the-art diagnostics require that bacterial DNA is recovered from the infection site. Because 60% of patients with invasive infections die within 7 d of culturing positive for MRSA, earlier detection of the pathogen may significantly reduce mortality. We aim to develop breath-based diagnostics that can detect Staphylococcal lung infections rapidly and non-invasively, and discriminate MRSA and methicillin-sensitive S. aureus (MSSA), in situ. Using a murine lung infection model, we have demonstrated that secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting can be used to robustly identify isogenic strains of MRSA and MSSA in the lung 24 h after bacterial inoculation. Principal components analysis (PCA) separates MRSA and MSSA breathprints using only the first component (p < 0.001). The predominant separation in the PCA is driven by shared peaks, low-abundance peaks, and rare peaks, supporting the use of biomarker panels to enhance the sensitivity and specificity of breath-based diagnostics.

Indexed as

AnimalsBreath TestsHumansMaleMethicillin-Resistant Staphylococcus aureusMiceMice, Inbred C57BLPrincipal Component AnalysisRespiratory Tract InfectionsSensitivity and SpecificitySpectrometry, Mass, Electrospray IonizationStaphylococcal Infections

Identifiers

PMID25307159
PMCPMC4443899
OpenAlexW2002942103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.